IT companies on an average returned 85% of profits to shareholders via dividends or buybacks, with less than 15% reinvested in capacities and capabilities; the case is almost inverse for pharma firms.
Having witnessed a prolonged period of benign inflation in the last decade, we should have expected FMCG companies to witness great volume growth, if not value. However, the opposite has been true
While that may be the case for some, investing outside of the large-cap universe, or rather companies that haven't hit maturity, is more guided by intuition or feeling rather than by calculations
If you are an investor who believes that buying equity is being a part-owner in a business, this fall in prices demands that you look beyond the prevailing narrative
Financial modeling can act as powerful compass to ascertain the direction of a business for long-term investors. Therefore, it should not only be treated as tool to ascertain EPS
52-week low lists become a common hunting ground to find investments among those that were the darlings of the market in the most recent run-up prior to the correction
Understanding smallcaps requires more than numbers. Harini Dedhia shares the single most important question to ask a smallcap company, to understand if it can truly scale and win market share
In order to build a thesis around which M&A deals to consider as a potential special situations investment, a look at the twenty largest deals by Indian companies in the past decade is instructive
In economics, the concept of a Laffer curve suggests that there is an optimal tax rate beyond which increasing the rate will not result in an increase in government revenue
Investing in PMS should be looked at as a test series. You can judge consistency on an ongoing basis but the outcome is drawn out as per the stated objective of the fund
